Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

NCT01527929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Malignant

Interventions

DRUG: Cabazitaxel XRP6258

Sponsor

Sanofi